Lucintel Forecasts The Global Sirna Conjugate Market To Reach $4 Billion By 2035

By Author: Lucintel LLC
Total Articles: 7757
Comment this article

According to a market report by Lucintel, the future of the global siRNA conjugate market looks promising with opportunities in the gene therapy and drug delivery markets. The global siRNA conjugate market is expected to reach an estimated $4 billion by 2035 with a CAGR of 13.5% from 2026 to 2035. The major drivers for this market are the increasing demand for gene therapies, the rising focus on targeted drug delivery, and the growing investment in molecular research.
A more than 150-page report to understand trends, opportunity and forecast in global siRNA conjugate market to 2035 by type (antibody-siRNA conjugates, GalNAc-siRNA conjugates, peptide-siRNA conjugates, and others), application (gene therapy, drug delivery, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, antibody-siRNA conjugate is expected to witness the highest growth over the forecast period.
Within the application category, gene therapy is expected to witness higher growth.
Download sample by clicking on siRNA conjugate market.
In terms ...
... of region, APAC is expected to witness the highest growth over the forecast period.
WuXi XDC, Creative Biogene, Bachem, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, Hitgen, Alnylam Pharmaceuticals, Amerigo Scientific are the major suppliers in the siRNA conjugate market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Benzyl Bromide Market
Candelilla Wax Market
Chlorine Trifluoride Market
Cocamide Diethanolamine Market
Collagen Hydrolysate Market